The circTADA2As as promising prognostic biomarkers in TNBC patients, and therapeutic targeting of circTADA2As/miRNA/mRNA network may be a potential strategy for the treatment of breast cancer.
circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis.